Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Craig Curhan, Sc.D., M.D.

Co-Author

This page shows the publications co-authored by Gary Curhan and Shveta Motwani.
Connection Strength

2.763
  1. Motwani SS, Curhan GC. Cisplatin-Associated Nephrotoxic Effects in Children. JAMA Netw Open. 2020 May 01; 3(5):e203612.
    View in: PubMed
    Score: 0.989
  2. Motwani SS, Curhan GC. Reply to T. Kurokawa et al. J Clin Oncol. 2018 08 10; 36(23):2454.
    View in: PubMed
    Score: 0.870
  3. Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC. Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 03 01; 36(7):682-688.
    View in: PubMed
    Score: 0.843
  4. Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O'Donnell EK, Jacobson CA, Motwani SS, Parikh SM, Curhan GC, Reynolds KL, Leaf DE, Sise ME. Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. Am J Kidney Dis. 2020 Jul; 76(1):63-71.
    View in: PubMed
    Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.